Daniela Scorpiniti Selected Research

Rituximab (Mabthera)

12/2021

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Scorpiniti Research Topics

Disease

5	COVID-19 12/2023 - 01/2021
2	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2023 - 12/2021
1	Cryoglobulinemia 01/2023

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 12/2023 - 12/2021
2	COVID-19 VaccinesIBA 12/2023 - 01/2023
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2021
2	Antirheumatic Agents (DMARD)IBA 01/2022 - 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	SteroidsIBA 01/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2021
1	Rituximab (Mabthera)FDA Link 12/2021
1	GlucocorticoidsIBA 12/2021